Latch Biosecurity
Company • latch.bio
This company focuses on GCBRs .
Latch Biosecurity, formed after LatchBio acquired TwentyTwo in June 2026, builds AI infrastructure for biosecurity, including automated customer screening, functional sequence screening and model safeguards. The former TwentyTwo team now leads Latch Biosecurity within LatchBio and has also contributed to AI-biosecurity evaluations and pathogen-surveillance research.
This company works on
- AI x Bio risks
- DNA synthesis
- Pathogen surveillance